AMD diagnostic test
Poor patient stratification
sound patient stratification
challenge of patient stratification
genetic diagnostic test
patient treatment
proper stratification of patients
treatment of patients
patient questionnaire
novel diagnostic test
higher complement activation levels
therapies
complement system
genetic predisposition
genetic testing
deregulated activation
novel diagnostic panel
Age-related MACULAr Degeneration
specific genetic makeup
clinical trials
systemic inflammation
drug development
high failure rates
alternative pathway
precision medicine approach
controls
MACULA2
statistical significance
cause of blindness
world
Pharmaceutical companies
inflammatory disease
approval
certain individuals
treatments